Goldman Sachs
CNMD icon

Goldman Sachs’s CONMED CNMD Stock Holding History

Goldman Sachs’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,000
Closed -$286K – 5237
2020
Q1 		$286K Buy
+5,000
New +$461K ﹤0.01% 4537
2014
Q3 		– Sell
-12,500
Closed -$552K – 7129
2014
Q2 		$552K Buy
+12,500
New +$567K ﹤0.01% 5220

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Goldman Sachs's CNMD Position: Q1 2026 in Review

Goldman Sachs reduced its CONMED (CNMD) stake by 0.78% in Q1 2026, selling an estimated $152K and leaving 476,648 shares worth $16.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

Goldman Sachs first reported a position in CNMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $86.5M in Q4 2021. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Goldman Sachs held 476,648 shares of CONMED worth $16.9M as of Q1 2026.
  • Goldman Sachs sold 3,724 CONMED shares in Q1 2026, an estimated $152K.
  • CONMED made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2596 holding.
  • Goldman Sachs first reported a position in CONMED in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's CONMED position peaked at $86.5M in Q4 2021.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.